Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination

Editorial Material Medicine, General & Internal

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

Tom Shimabukuro et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

COVID-19 Vaccine-Induced Radiation Recall Phenomenon

Viacheslav Soyfer et al.

Summary: Radiation recall phenomenon (RRP) is a rare acute inflammatory skin reaction that can occur in patients who have previously undergone radiation therapy, triggered by various chemotherapy agents. This report is the first to describe RRP after receiving the Pfizer-BioNTech COVID-19 vaccine. It is important to consider the potential risk of RRP in cancer patients undergoing radiation therapy with significant skin doses when receiving COVID-19 vaccinations.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Letter Dermatology

Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination

A. M. Carballido Vazquez et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Letter Dermatology

Improving cultural competency and practicing cultural humility in dermatologic training: Skin of color education and board certification

Trisha Kaundinya et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

添加到收藏夹

Letter Dermatology

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization

D. Fernandez-Nieto et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Letter Dermatology

Lichen planus arising after COVID-19 vaccination

I. Hiltun et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Letter Dermatology

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine

B. M. Cyrenne et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Article Dermatology

Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine A Case Series

Margaret S. Johnston et al.

Summary: In response to the COVID-19 pandemic, mRNA vaccines from Pfizer-BioNTech and Moderna received emergency use authorization in the US. This study focused on localized cutaneous reactions to the Moderna COVID-19 vaccine, finding them to be delayed hypersensitivity reactions that are self-limited and not associated with serious adverse effects. Most patients who had a reaction to the first vaccine dose also developed a similar reaction to the second dose, typically sooner. The reactions, dubbed COVID arm, are not a contraindication to subsequent vaccination.

JAMA DERMATOLOGY (2021)

添加到收藏夹

Review Immunology

Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review

Harrison Bell et al.

VACCINE (2020)

添加到收藏夹

Article Dermatology

Anti-Laminin-332 Mucous Membrane Pemphigoid Developing After a Diphtheria Tetanus Vaccination

Tanya Sezin et al.

JAMA DERMATOLOGY (2013)

添加到收藏夹

Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination

相关参考文献

导出引文

分享论文